Gemcitabine and carboplatin in combination for the treatment of advanced, metastatic, non-small cell lung cancer

被引：9
|
作者：
Nagel, Sylke [3 ]
Califano, Raffaele [2 ]
Thatcher, Nicholas [1 ]
Blackhall, Fiona [1 ]
机构：
[1] Christie Hosp, Dept Med Oncol, Manchester M20 4BX, Lancs, England
[2] Osped Santa Maria Misericordia, SC Oncol Med, I-06120 Perugia, Italy
[3] Martha Maria Hosp, D-06120 Halle, Germany
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2007年 / 8卷 / 18期
关键词：
carboplatin; chemotherapy; gemcitabine; non-small-cell lung cancer;
D O I：
10.1517/14656566.8.18.3265
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The universally accepted first-line treatment for advanced (stage IIIB effusion/IV) non-small-cell lung cancer in patients with a good performance status is a platinum drug in combination with one of gemcitabine, paclitaxel, vinorelbine or docetaxel. Although cisplatin is generally the favoured platinum agent, gemcitabine partnered with carboplatin is convenient to administer and has a favourable toxicity profile. Here, the pharmacology, preclinical and clinical data to support the use of this regimen for the treatment of advanced non-small-cell lung cancer is evaluated.
引用
收藏
页码：3265 / 3275
页数：11
相关论文
共 50 条
  • [21] The proteasome inhibitor bortezomib in combination with gemcitabine and carboplatin in advanced non-small cell lung cancer: A california cancer consortium phase I study
    Davies, Angela M.
    Ruel, Christopher
    Lara, Primo N.
    Lau, Derick H.
    Gumerlock, Paul H.
    Bold, Richard
    Shibata, Stephen
    Lenz, Heinz-Josef
    Schenkein, David P.
    Gandara, Anddavid R.
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (01) : 68 - 74
  • [22] Comparison of gemcitabine/carboplatin versus paclitaxel/cisplatin for the management of non-small cell lung cancer
    Wang, Wei
    Li, Wenli
    Dai, Lili
    Zhao, Lei
    Qu, Kaixin
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2022, 21 (08) : 1763 - 1770
  • [23] Gemcitabine: Efficacy in the Treatment of Advanced Stage Nonsquamous Non-Small Cell Lung Cancer
    Hayashi, Hidetoshi
    Kurata, Takayasu
    Nakagawa, Kazuhiko
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2011, 5 : 177 - 184
  • [24] Carboplatin and Gemcitabine in First-Line Treatment of Elderly Patients with Advanced Non-Small Cell Lung Cancer: Data from a Retrospective Study
    Genestreti, G.
    Giovannini, N.
    Frizziero, M.
    Maglie, M.
    Sanna, S.
    Cingarlini, S.
    Molino, A. M.
    Piciucchi, S.
    Cetto, G. L.
    Santo, A.
    JOURNAL OF CHEMOTHERAPY, 2011, 23 (04) : 232 - 237
  • [25] Carboplatin and vinorelbine in untreated locally advanced and metastatic non-small cell lung cancer
    Horvath, L
    Boyer, M
    Clarke, S
    Beale, P
    Beith, J
    Underhill, C
    Stockler, M
    Bishop, J
    LUNG CANCER, 2001, 32 (02) : 173 - 178
  • [26] THE COMBINATION CHEMOTHERAPY OF BEVACIZUMAB PLUS GEMCITABINE AND CARBOPLATIN IN PATIENTS WITH ADVANCED SQUAMOUS NON-SMALL CELL LUNG CANCER
    Kim, Taekyu
    Ahn, Young Mi
    Nam, Seung-hyun
    Kim, Bong-seog
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S488 - S488
  • [27] Doublet gemcitabine-platin in the treatment of non-small cell lung cancer
    Souquet, PJ
    Gerinière, L
    BULLETIN DU CANCER, 2002, 89 : S80 - S84
  • [28] Combination therapy with gemcitabine in non-small cell lung cancer
    Mosconi, AM
    Crino, L
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : S14 - S17
  • [29] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Lin Run Wang
    Ming Zhu Huang
    Guo Bing Zhang
    Nong Xu
    Xiu Hua Wu
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 601 - 607
  • [30] Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer
    Wang, Lin Run
    Huang, Ming Zhu
    Zhang, Guo Bing
    Xu, Nong
    Wu, Xiu Hua
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (04) : 601 - 607
12345